Remove Financial Market Remove Medicine Remove Portfolio
article thumbnail

2025 Q1 Update: Federal Reserve Rates, Inflation and Financial Markets

Your Richest Life

The cost increase last month affected expenses like car insurance, airfare, medicine and groceries. 2025 may prove to be a bumpy ride, but a strong, well-balanced portfolio is designed to weather storms. The post 2025 Q1 Update: Federal Reserve Rates, Inflation and Financial Markets appeared first on Your Richest Life.

article thumbnail

Cipla Vs Sun Pharmaceutical – Financials, Future Plans & More

Trade Brains

Cipla Vs Sun Pharmaceutical : Pharma companies bear enormous responsibility for producing medicines and monetizing the time and effort spent on research and development for years by using patent protection. Sun Pharma’s portfolio includes innovative specialty medicines, branded generics, pure generics, and APIs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Sigachi Industries: Fueling Pharma Growth with High-Quality MCC

Trade Brains

We all know that the pharmaceutical industry is a complex ecosystem where countless components converge to produce life – saving medicines. MCC being a non medicinal ingredient plays a critical role in formulating tablets, capsules and other dosage forms.

article thumbnail

Fundamental Analysis Of Zydus Lifesciences – Financials & More Details

Trade Brains

Industry Overview India is the 12th-largest market in terms of value and the world’s third-largest pharmaceutical manufacturer in terms of volume. The Indian pharmaceutical sector includes over-the-counter medicines, generic medications, bulk drugs, vaccines, contract research and manufacture, biosimilars, and biologics.

article thumbnail

Fundamental Analysis Of Divis Laboratories – Profitability & More

Trade Brains

Overview: Indian Pharmaceutical Industry When you consume medicine for certain ailments and diseases, you’re recommended by your doctor to consume it for its curing effect. Some notable pharmaceutical companies have made their way to the Nifty Index and we’re going to perform a fundamental analysis of Divis Laboratories. FY 19 0.015 531.02

article thumbnail

Fundamental Analysis Of Lupin – Industry Analysis and Financials

Trade Brains

Fundamental Analysis Of Lupin : Medicines are substances that can be used to prevent, treat, or cure disease. Pharmaceutical companies in India have come a long way in supplying medicines, and with more research, they are improving their products. Segment Analysis The company’s revenue was Rs. crore in FY23.

article thumbnail

Cipla Vs Dr. Reddy’s Laboratories – Financials, Future Plans & More

Trade Brains

It is the world’s largest supplier of generic medicine, in terms of volume with a 20% market share. According to the Economic Survey 2023, India’s domestic pharmaceutical market was estimated at $41 billion. This portfolio is boosted by the successful launch of gRevlimid. Reddy’s Laboratories Ltd.